Further solidifies global leadership in differentiated, genomics-driven cancer diagnostics and expands TAM with presence in 7 of the 10 most common cancers “Bringing Decipher into the Veracyte family ...
SAN DIEGO, Feb. 14, 2019 /PRNewswire/ -- Decipher Biosciences (formerly GenomeDx Inc.), a leader in the field of urologic cancer genomics, today announced that it will present results from seven ...
Decipher Biosciences, which provides genomic testing products for urologic oncology, filed on Tuesday with the SEC to raise up to $100 million in an initial public offering. Decipher's prostate cancer ...
SAN DIEGO, Dec. 3, 2019 /PRNewswire/ -- Decipher Biosciences, a leader in the field of urologic cancer genomics, today announced that Palmetto GBA, a Medicare Administrative Contractor (MAC), issued a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback